

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Bax ↓ ↑ | Bcl-2 ↓ ↑ | Bcl-B ↓ ↑ | Bcl-w ↓ ↑ | Bcl-xL ↓ ↑ | Bfl-1 ↓ ↑ | Mcl-1 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BTSA1 | ✔ | 99%+ | |||||||||||||||||
| HA14-1 |
+
Bcl-2, IC50: 9 μM |
98% | |||||||||||||||||
| Venetoclax |
++++
Bcl-2, Ki: <0.01 nM |
99% | |||||||||||||||||
| Navitoclax | 99%+ | ||||||||||||||||||
| Obatoclax Mesylate |
+++
Bcl-2, Ki: 0.22 μM |
99% | |||||||||||||||||
| ABT-737 |
+++
Bcl-2, EC50: 30.3 nM |
+
Bcl-B, EC50: 1.82 μM |
+++
Bcl-w, EC50: 197.8 nM |
+++
Bcl-xL, EC50: 78.7 nM |
99%+ | ||||||||||||||
| Gambogic Acid |
+
Bcl-2, IC50: 1.21 μM Bfl-1, IC50: 1.06 μM |
++
Bcl-B, IC50: 0.66 μM |
++++
Bcl-w, IC50: 0.02 μM |
+
Bcl-xL, IC50: 1.47 μM |
+
Bfl-1, IC50: 1.06 μM |
++
Mcl-1, IC50: 0.79 μM |
Caspase | 99% HPLC | |||||||||||
| BH3I-1 |
+
BH3-Bcl-xL interaction, Ki: 2.4 μM |
99% | |||||||||||||||||
| A-1331852 |
++++
Bcl-xL, Ki: <0.01 nM |
99%+ | |||||||||||||||||
| A-1210477 |
++++
MCL-1, IC50: 26.2 nM |
99%+ | |||||||||||||||||
| Maritoclax | ✔ | 97% | |||||||||||||||||
| TW-37 |
+++
Bcl-2, Ki: 0.29 μM |
+
Bcl-xL, Ki: 1.11 μM |
+++
Mcl-1, Ki: 0.26 μM |
98% | |||||||||||||||
| UMI-77 |
++
Mcl-1, Ki: 490 nM |
97% | |||||||||||||||||
| (R)-(-)-Gossypol acetic acid |
++
Bcl-2, Ki: 0.32 μM |
++
Bcl-xL, Ki: 0.48 μM |
+++
Mcl-1, Ki: 0.18 μM |
99% | |||||||||||||||
| Sabutoclax |
++
Bcl-2, IC50: 0.32 μM Bfl-1, IC50: 0.62 μM |
++
Bcl-xL, IC50: 0.31 μM |
++
Bfl-1, IC50: 0.62 μM |
+++
Mcl-1, IC50: 0.20 μM |
98% | ||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Mcl-1 (Myeloid cell leukemia-1) is an anti-apoptotic protein, which is a member of the Bcl-2 family. Mcl-1 is involved in the regulation of apoptosis versus cell survival, and in the maintenance of cell viability but not of proliferation. Mcl-1 mediates its effects by interactions with a number of other regulators of apoptosis[3]. UMI-77 is a Mcl-1 inhibitor. In FP-based binding assays, UMI-77 potently and selectively displaced fluorescent labeled BID-BH3 peptide from Mcl-1 protein. UMI-77 bound to the BH3 binding pocket of Mcl-1 and the Ki value was 0.49 μM[4]. In a pull-down assay, starting from the concentration of 10 μM , UMI-77 dose-dependently inhibited the interactions between BL-Noxa and cellular Mcl-1 in 2LMP cell lysates. In a SPR-based binding assay, it was reported that UMI-77 dose-dependently inhibited the binding of Mcl-1 to Bax with IC50 value of 1.43 μM. UMI-77 inhibited the growth of BxPC-2 and Panc-1 cells with IC50 values of 3.4 μM and 4.4 μM, respectively[4]. UMI-77 incubated at the concentrations of 3 μM or 10 μM for 48h induced apoptosis in esophageal squamous cell carcinoma KYSE150 and KYSE510 cells, as evidenced by cleavage of caspase-3 and PARP[5]. In BxPC-3 xenograft model established in SCID mice, UMI-77 administrated i.v. at the dose of 60 mg/kg for a total of 10 doses significantly inhibited tumor growth[4]. |
| 作用机制 | UMI-77 is a Mcl-1 inhibitor. Docking and spectroscopy studies revealed that UMI-77 bound to the BH3 binding pocket of Mcl-1[4]. |
| Concentration | Treated Time | Description | References | |
| HEK293T | 5 µM | 12 hours | UMI-77 induces mitophagy without causing mitochondrial damage or apoptosis. | Nat Commun. 2020 Nov 12;11(1):5731. |
| ME4405 cells | 4 µM | 24 hours | To evaluate the apoptosis-inducing effect of UMI-77 on ME4405 cells, results showed that OVAAL overexpression conferred resistance to UMI-77-induced apoptosis. | Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11661-E11670. |
| HCT116 cells | 4 µM | 24 hours | To evaluate the apoptosis-inducing effect of UMI-77 on HCT116 cells, results showed that OVAAL knockdown enhanced UMI-77-induced apoptosis. | Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11661-E11670. |
| BxPC-3 cells | 3.4 µM (IC50) | 4 days | UMI-77 inhibits BxPC-3 cell growth with IC50 of 3.4 μM | Mol Cancer Ther. 2014 Mar;13(3):565-75. |
| Panc-1 cells | 4.4 µM (IC50) | 4 days | UMI-77 inhibits Panc-1 cell growth with IC50 of 4.4 μM | Mol Cancer Ther. 2014 Mar;13(3):565-75. |
| MiaPaCa-2 cells | 12.5 µM (IC50) | 4 days | UMI-77 inhibits MiaPaCa-2 cell growth with IC50 of 12.5 μM | Mol Cancer Ther. 2014 Mar;13(3):565-75. |
| AsPC-1 cells | 16.1 µM (IC50) | 4 days | UMI-77 inhibits AsPC-1 cell growth with IC50 of 16.1 μM | Mol Cancer Ther. 2014 Mar;13(3):565-75. |
| Capan-2 cells | 5.5 µM (IC50) | 4 days | UMI-77 inhibits Capan-2 cell growth with IC50 of 5.5 μM | Mol Cancer Ther. 2014 Mar;13(3):565-75. |
| MN9D cells | 10 µM | 4 hours | UMI-77 significantly increased the level of cleaved caspase-3 in MN9D cells and induced cell death. | Cell Death Discov. 2018 Nov 21;4:107. |
| N2A cells | 10 µM | 4 hours | UMI-77 had no significant effect on the level of cleaved caspase-3 in N2A cells. | Cell Death Discov. 2018 Nov 21;4:107. |
| AGS cells | 8 µM (IC50) | 48 hours and 72 hours | To evaluate the sensitivity of AGS cells to UMI-77, results showed that AGS cells were more sensitive to UMI-77. | Front Immunol. 2024 Jun 27;15:1428529. |
| MKN45 cells | 125 µM (IC50) | 48 hours and 72 hours | To evaluate the sensitivity of MKN45 cells to UMI-77, results showed that MKN45 cells were less sensitive to UMI-77. | Front Immunol. 2024 Jun 27;15:1428529. |
| NB4 cells | 15–30 µM | 6 hours | UMI-77 induced NOXA protein expression within 6 hours and resulted in extensive PARP cleavage in NB4 cells after 12 hours, indicating indirect inhibition of MCL1 through NOXA induction. | Cell Death Dis. 2019 Feb 22;10(3):185. |
| Jurkat cells | 15–30 µM | 6 hours | UMI-77 induced NOXA protein expression within 6 hours, indicating indirect inhibition of MCL1 through NOXA induction. | Cell Death Dis. 2019 Feb 22;10(3):185. |
| U937 cells | 15–30 µM | 6 hours | UMI-77 induced NOXA protein expression within 6 hours, indicating indirect inhibition of MCL1 through NOXA induction. | Cell Death Dis. 2019 Feb 22;10(3):185. |
| HeLa | 5 µM | 8 hours | UMI-77 promotes degradation of mitochondrial proteins without affecting endoplasmic reticulum or cytosolic markers. | Nat Commun. 2020 Nov 12;11(1):5731. |
| HGPS-MSCs | 1 µM | UMI-77 significantly improved the mitochondrial function of HGPS-MSCs, as evidenced by decreased ROS levels, reduced mitochondrial depolarization, and increased basal and maximal respiration levels. | Aging Cell. 2024 Jun;23(6):e14143. | |
| Administration | Dosage | Frequency | Description | References | ||
| Pitx3GFP/+ mice | Pitx3GFP/+ mice | Brain slice culture | 10 µM | Overnight treatment | UMI-77 treatment increased the number of cleaved caspase-3 positive cells in brain slices of Pitx3GFP/+ mice, indicating that Mcl1 plays a crucial role in the survival of dopaminergic neurons. | Cell Death Discov. 2018 Nov 21;4:107. |
| APP/PS1 (C57BL/6) mice | APP/PS1 mouse model | Intraperitoneal injection | 10 mg/kg | Every other day for 4 months | UMI-77 significantly improved learning and memory in APP/PS1 mice, reduced Aβ plaques and neuroinflammation, and restored mitochondrial morphology. | Nat Commun. 2020 Nov 12;11(1):5731. |
| Mice | LmnaG608G/G608G mice | Intragastric administration | 20 mg/kg | Every other day for 5 months | UMI-77 restored mitochondrial morphology and function in HGPS mice, reduced aging-related tissue changes (such as loss of collagen fibers in the skin and fibrosis in the aorta, heart, muscles, and spleen), and significantly improved the overall health of the mice, including increased hair and weight, enhanced skeletal muscle strength, spatial working memory, and mobility, and extended the lifespan of the mice. | Aging Cell. 2024 Jun;23(6):e14143. |
| Mice | C57/BL6J mice | Intraperitoneal injection | 5 mg/kg | Once daily for 14 days or 49 days | UMI-77 promotes mitophagy in the hippocampus of adult mice, enhances neurogenesis, and prolongs the duration of spatial memory. | CNS Neurosci Ther. 2024 Jun;30(6):e14800 |
| SCID mice | BxPC-3 xenograft model | Intravenous injection | 60 mg/kg | 5 days per week for 2 weeks | UMI-77 significantly inhibited tumor growth in the BxPC-3 xenograft model | Mol Cancer Ther. 2014 Mar;13(3):565-75. |
| BALB/c mice | Sepsis-induced acute lung injury model | Intraperitoneal injection | 7.0 mg/kg | Once daily for five days | UMI-77 significantly ameliorated histopathological changes in the lungs of mice with sepsis-induced ALI and exerted therapeutic effects by modulating key genes and metabolites. | J Inflamm Res. 2024 Dec 18;17:11197-11209 |
| Dose | Mice: 60 mg/kg[2] (i.v.) |
| Administration | i.v. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.14mL 0.43mL 0.21mL |
10.68mL 2.14mL 1.07mL |
21.35mL 4.27mL 2.14mL |
|
| CAS号 | 518303-20-3 |
| 分子式 | C18H14BrNO5S2 |
| 分子量 | 468.34 |
| SMILES Code | O=C(O)CSC1=CC(NS(=O)(C2=CC=C(Br)C=C2)=O)=C3C=CC=CC3=C1O |
| MDL No. | MFCD03471890 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | WUGANDSUVKXMEC-UHFFFAOYSA-N |
| Pubchem ID | 992586 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 30 mg/mL(64.06 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1